Parker Hannifin
PH
$1060.50
-1.25%
Parker-Hannifin Corporation is a global leader in motion and control technologies, providing precision-engineered solutions for aerospace, industrial, and mobile markets, including hydraulic, electromechanical, and filtration systems. The company differentiates itself through its highly engineered, mission-critical components and systems that enable cross-selling across diverse end markets, positioning it as a key player in the industrial machinery sector. Currently, the investor narrative centers on Parker's strategic acquisitions, such as the planned purchase of CIRCOR's aerospace business, which is expected to enhance growth and margins, alongside its robust performance in the aerospace segment and ongoing operational efficiency initiatives. The stock's recent surge to record highs reflects optimism about its growth trajectory and the successful execution of its Win Strategy, though debates persist around valuation sustainability and cyclical risks in industrial demand.…
PH
Parker Hannifin
$1060.50
Related headlines
Investment Opinion: Should I buy PH Today?
Based on the analysis, Parker-Hannifin is rated a 'Buy' with a thesis that its strong revenue growth, margin expansion, and strategic acquisitions will drive earnings growth, justifying the forward P/E of 28.6x. The analyst consensus is 'Buy' with an average target of $1,039.70, implying a slight downside from the current price of $1,069.80, but the high target of $1,269 offers 18.6% upside. Supporting evidence includes 10.6% YoY revenue growth, operating margin expansion to 20.7%, TTM free cash flow of $3.68B, and a forward P/E of 28.6x, which is reasonable for a company with expected EPS growth of 25% next year. The main risks are cyclicality and valuation; if revenue growth falls below 5% or the forward P/E compresses to 20x, the rating would be downgraded to 'Hold'. Overall, the stock is fairly valued relative to its growth prospects, but not a bargain.
Sign up to view all
PH 12-Month Price Forecast
The AI assessment leans bullish, driven by accelerating revenue growth and a reasonable forward P/E relative to expected earnings growth. However, the elevated trailing P/E and cyclical risks temper confidence. The stance would be upgraded to 'high confidence' if revenue growth sustains above 10% and margins expand, or downgraded to 'neutral' if industrial indicators weaken or the CIRCOR integration faces delays.
Wall Street consensus
Most Wall Street analysts maintain a constructive view on Parker Hannifin's 12-month outlook, with a consensus price target around $1133.59 and implied upside of +6.9% versus the current price.
Average Target
$1133.59
0 analysts
Implied Upside
+6.9%
vs. current price
Analyst Count
—
covering this stock
Price Range
$680 - $1358
Analyst target range
The target price range spans from a low of $680.00 to a high of $1,269.00, with the high target implying a 18.6% upside from the current price, while the low target suggests a -36.4% downside. This wide spread of $589 indicates significant uncertainty about the stock's future, likely due to cyclicality and valuation concerns. Recent institutional actions show a mix of reaffirmations and no downgrades, with firms like Truist, Wells Fargo, and JP Morgan maintaining positive ratings, while Morgan Stanley holds an Equal Weight stance. The high target assumes continued aerospace growth and successful integration of acquisitions, while the low target reflects potential margin compression or a cyclical downturn. Overall, the consensus leans bullish, but the stock's current price above the average target suggests limited near-term upside based on analyst estimates.
Bulls vs Bears: PH Investment Factors
Parker-Hannifin presents a compelling growth story with strong revenue acceleration, margin expansion, and strategic acquisitions, but the elevated valuation and cyclical exposure introduce significant risks. The bull case is currently stronger, supported by robust fundamentals and positive analyst sentiment, yet the stock trades near its 52-week high, leaving limited margin of safety. The key tension is whether the company can sustain its growth trajectory to justify the forward P/E of 28.6x, or if a cyclical downturn will compress earnings and multiples, leading to a sharp correction.
Bullish
- Strong Revenue Growth: Q3 FY2026 revenue grew 10.6% YoY to $5.486B, with sequential acceleration from $5.084B in Q1 to $5.486B in Q3, indicating robust demand across aerospace and industrial segments.
- High Margin Expansion: Operating margin improved to 20.7% in Q3 FY2026 from 19.8% in the year-ago quarter, driven by operational efficiency and favorable mix, supporting earnings growth.
- Aerospace Growth Catalyst: Aerospace Systems segment generated $1.706B in revenue, benefiting from strong commercial and defense demand, with the CIRCOR acquisition expected to further boost growth and margins.
- Analyst Consensus Buy: With 23 analysts, the consensus rating is 'Buy' (mean 1.68), and the average target price of $1,039.70 implies a modest 2.8% downside, but the high target of $1,269 suggests 18.6% upside.
Bearish
- Elevated Valuation: Trailing P/E is 112.9x due to one-time items, but forward P/E of 28.6x is still above the industrial sector median, implying high growth expectations that may not materialize.
- Cyclicality Risk: With a beta of 1.13, the stock is sensitive to economic cycles; a downturn in industrial demand could pressure revenue and margins, as seen in past cyclical downturns.
- Wide Analyst Target Range: Analyst targets range from $680 to $1,269, a spread of $589, indicating significant uncertainty about future performance, with the low target implying a 36.4% downside.
- High Payout Ratio: The dividend payout ratio is 85.8%, leaving limited room for dividend growth or reinvestment, which could constrain shareholder returns if earnings falter.
PH Technical Analysis
Parker-Hannifin's stock is in a strong uptrend, with a 1-year price change of +53.5% and a 6-month change of +9.6%, indicating sustained momentum. The current price of $1,069.80 sits near the top of its 52-week range, at approximately 97.4% of the high of $1,098.80, signaling bullish sentiment and potential overextension. The stock's relative strength versus the S&P 500 is notable, with a 1-year relative strength of +32.0%, underscoring its outperformance in the broader market context.
Beta
1.13
1.13x market volatility
Max Drawdown
-19.5%
Largest decline past year
52-Week Range
$715-$1100
Price range past year
Annual Return
+45.7%
Cumulative gain past year
| Period | PH Return | S&P 500 |
|---|---|---|
| 1m | +10.3% | +2.4% |
| 3m | +20.3% | +4.7% |
| 6m | +6.5% | +11.7% |
| 1y | +45.7% | +21.3% |
| ytd | +18.6% | +13.4% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
PH Fundamental Analysis
Parker-Hannifin's revenue trajectory remains robust, with the most recent quarter (Q3 FY2026) reporting revenue of $5.486 billion, up 10.6% year-over-year, and a sequential increase from $5.174 billion in Q2 FY2026. The company's growth is driven by its Aerospace Systems segment, which generated $1.706 billion in revenue, and the Diversified Industrial segment at $3.468 billion, reflecting broad-based demand. Over the past four quarters, revenue has grown from $5.084 billion in Q1 FY2026 to $5.486 billion in Q3, indicating accelerating momentum, which supports the investment case for continued expansion.
Quarterly Revenue
$5.5B
2026-03
Revenue YoY Growth
+10.6%
YoY Comparison
Gross Margin
36.8%
Latest Quarter
Free Cash Flow
$3.7B
Last 12 Months
Revenue & Net Income Trends (2 Years)
Revenue Breakdown
Open an Account, get $2 TSLA now!
Valuation Analysis: Is PH Overvalued?
Given Parker-Hannifin's positive net income, the trailing P/E ratio is the primary valuation metric, currently at 112.9x, which is elevated due to one-time items, while the forward P/E of 28.6x provides a more normalized view. The gap between trailing and forward P/E implies the market expects significant earnings growth, with consensus EPS estimates of $45.70 for the next fiscal year, representing a 25% increase from current levels. This suggests the market is pricing in strong future performance, but the trailing multiple is distorted by non-recurring charges, making the forward multiple more relevant for comparison.
PE
112.9x
Latest Quarter
vs. Historical
High-End
5-Year PE Range 18x~33x
vs. Industry Avg
N/A
Industry PE ~N/A*
EV/EBITDA
83.0x
Enterprise Value Multiple
Investment Risk Disclosure
Financially, Parker-Hannifin carries a moderate debt-to-equity ratio of 0.52, but the high payout ratio of 85.8% limits financial flexibility, and the trailing P/E of 112.9x is distorted by one-time items, making the forward P/E of 28.6x more relevant. The company's reliance on continued revenue growth (10.6% YoY) to justify its valuation is a key risk; any deceleration could lead to multiple compression. Additionally, the operating margin of 20.7% is solid but could be pressured by rising input costs or integration issues from the CIRCOR acquisition.
FAQ
The key risks are: (1) Cyclicality: With a beta of 1.13, PH is sensitive to economic downturns, and a recession could significantly reduce demand for its industrial products. (2) Valuation risk: The forward P/E of 28.6x leaves little room for error; any earnings miss could trigger multiple compression. (3) Integration risk: The CIRCOR acquisition may face execution challenges, potentially hurting margins and growth. (4) Dividend sustainability: The payout ratio of 85.8% is high, leaving limited room for dividend increases if earnings decline. These risks are ranked by severity, with cyclicality being the most significant.
The 12-month forecast for PH is moderately bullish, with a base case probability of 50% targeting a range of $950-$1,100, aligning with the average analyst target of $1,039.70. The bull case (30% probability) targets $1,150-$1,269, driven by strong aerospace growth and successful integration, while the bear case (20% probability) targets $680-$850, reflecting a cyclical downturn. The most likely scenario is the base case, assuming continued revenue growth of 8-10% and stable margins. Investors should monitor quarterly earnings for signs of acceleration or deceleration.
PH's valuation is elevated relative to its historical averages and the broader market. The trailing P/E of 112.9x is distorted by one-time items, but the forward P/E of 28.6x is above the industrial sector median, indicating the market expects strong growth. Compared to its own history, the stock trades at a premium, reflecting optimism about its aerospace segment and the CIRCOR acquisition. The market is pricing in sustained double-digit earnings growth, which may be optimistic given cyclical risks. Overall, the stock is fairly valued if growth materializes, but overvalued if it disappoints.
PH is a good buy for investors with a long-term horizon and tolerance for cyclicality. The stock offers a forward P/E of 28.6x, which is reasonable given expected EPS growth of 25%, and the analyst consensus is 'Buy' with a high target implying 18.6% upside. However, the current price is near the 52-week high, and the low target suggests a 36.4% downside, so investors should consider dollar-cost averaging or waiting for a pullback. The biggest risk is a cyclical downturn, which could compress earnings and multiples, but the company's strong free cash flow and strategic acquisitions provide a buffer.
PH is more suitable for long-term investment due to its cyclical nature and high valuation. The stock has a beta of 1.13, indicating higher volatility than the market, which can lead to significant short-term swings. However, its strong fundamentals, including 10.6% revenue growth and a solid balance sheet, support long-term value creation. The dividend yield of 0.76% is modest, but the company's growth prospects and strategic acquisitions offer capital appreciation potential. A minimum holding period of 3-5 years is recommended to ride out cyclical downturns and benefit from earnings growth.